Evidence map›Paper›PMID 40897663›Full record

Observational studyInvestigative and clinical urology2025

Antibiotic prophylaxis in ambulatory cystoscopy: Challenging its role even in high-risk patients-prospective observational study.

Dolev Perez, Ariel Mamber, Michael Pasherstnik, Dmitry Koulikov, Ala Eddin Natsheh, Ofer Z Shenfeld, Avital Zeldin, Benymin Tzair, Boris Chertin, Ilan Z Kafka

Abstract readObservational Study
In one paragraph

Observational study in Investigative and clinical urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dolev PerezDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel. drdolevperez@gmail.com.ORCID 0000-0002-4969-7019
Ariel MamberDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0009-0005-7375-1512
Michael PasherstnikDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0009-0007-3401-9964
Dmitry KoulikovDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.
Ala Eddin NatshehDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0009-0001-9847-409X
Ofer Z ShenfeldDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0002-1286-5488
Avital ZeldinDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0009-0001-1876-5904
Benymin TzairDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.
Boris ChertinDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0002-8347-0969
Ilan Z KafkaDepartment of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.ORCID 0000-0001-8024-351X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCystoscopy is a commonly performed outpatient urological procedure, with post-procedural urinary tract infections (UTIs) being a key concern. It is generally safe, but high-risk individuals (e.g., diabetics, chronic obstructive pulmonary disease [COPD], immunodeficiency) have a higher risk for potential UTIs. This study evaluates the effectiveness of antibiotic prophylaxis in preventing post-cystoscopy UTIs. MATERIALS AND

methodsA prospective observational study was conducted in 2023, enrolling 300 adult patients undergoing ambulatory flexible cystoscopy who were divided into two cohorts: cystoscopy with and without antibiotic prophylaxis. The primary outcome was UTI incidence within four weeks post-procedure, defined by a positive urine culture (>10⁵ CFU/mL) and accompanying symptoms, antibiotic prescriptions, or emergency visits. Positive urine cultures confirmed the primary outcomes.

resultsThe study involved 300 patients: 150 received antibiotic prophylaxis (Cohort A), and 150 did not (Cohort B), showing no significant differences in clinical and demographic variables. UTI incidence was 9.3% in Cohort A and 10.0% in Cohort B, with no statistically significant difference (p=0.510). No cases of urinary sepsis were observed. Risk factors such as diabetes, ischemic heart disease, and COPD were evenly distributed across both cohorts.

conclusionsAntibiotic prophylaxis did not significantly reduce post-cystoscopy UTI rates. These findings suggest that routine prophylactic antibiotic use may be unnecessary in low-risk patients, reinforcing the need for antibiotic stewardship. Further large-scale studies are warranted to refine clinical guidelines.

Indexed as

Antibiotic ProphylaxisCystoscopyUrinary Tract InfectionsAdultAgedAmbulatory CareAnti-Bacterial AgentsFemaleHumansIncidenceMaleMiddle AgedProspective StudiesRisk FactorsAnti-Bacterial AgentsAntibiotic prophylaxisCultureCystoscopyUrinary tract infections

Identifiers

PMID40897663
PMCPMC12437578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.